The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Neuropathic Pain Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).
The global Neuropathic Pain Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Neuropathic Pain Drugs in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Neuropathic Pain Drugs market. Tricyclic Anti-Depressants Anticonvulsants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Serotonin-Norepinephrine Reuptake Inhibitor segment is estimated at % CAGR for the next seven-year period.
In terms of value, North America is a large market and is expected to increase at over 5% CAGR during the forecast period. The Asia Pacific neuropathic pain management market is projected to show fast growth and it is projected grow at CAGR of 6% over the forecast period due to increasing prevalence of diabetes in Asia Pacific, particularly in China and India.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuropathic Pain Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neuropathic Pain Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuropathic Pain Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuropathic Pain Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuropathic Pain Drugs covered in this report include Pfizer, Johnson & Johnson, Sanofi, GlaxoSmithKline, Eli Lilly, Bristol-Myers Squibb, Biogen, Baxter Healthcare and Depomed, etc.
The global Neuropathic Pain Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Johnson & Johnson
Sanofi
GlaxoSmithKline
Eli Lilly
Bristol-Myers Squibb
Biogen
Baxter Healthcare
Depomed
Global Neuropathic Pain Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuropathic Pain Drugs market, Segment by Type:
Tricyclic Anti-Depressants Anticonvulsants
Serotonin-Norepinephrine Reuptake Inhibitor
Capsaicin Cream
Local Anaesthesia
Opioids
Steroids
Others
Global Neuropathic Pain Drugs market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neuropathic Pain Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).
The global Neuropathic Pain Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Neuropathic Pain Drugs in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Neuropathic Pain Drugs market. Tricyclic Anti-Depressants Anticonvulsants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Serotonin-Norepinephrine Reuptake Inhibitor segment is estimated at % CAGR for the next seven-year period.
In terms of value, North America is a large market and is expected to increase at over 5% CAGR during the forecast period. The Asia Pacific neuropathic pain management market is projected to show fast growth and it is projected grow at CAGR of 6% over the forecast period due to increasing prevalence of diabetes in Asia Pacific, particularly in China and India.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuropathic Pain Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neuropathic Pain Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuropathic Pain Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuropathic Pain Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuropathic Pain Drugs covered in this report include Pfizer, Johnson & Johnson, Sanofi, GlaxoSmithKline, Eli Lilly, Bristol-Myers Squibb, Biogen, Baxter Healthcare and Depomed, etc.
The global Neuropathic Pain Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Johnson & Johnson
Sanofi
GlaxoSmithKline
Eli Lilly
Bristol-Myers Squibb
Biogen
Baxter Healthcare
Depomed
Global Neuropathic Pain Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuropathic Pain Drugs market, Segment by Type:
Tricyclic Anti-Depressants Anticonvulsants
Serotonin-Norepinephrine Reuptake Inhibitor
Capsaicin Cream
Local Anaesthesia
Opioids
Steroids
Others
Global Neuropathic Pain Drugs market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neuropathic Pain Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Neuropathic Pain Drugs
1.1 Neuropathic Pain Drugs Market Overview
1.1.1 Neuropathic Pain Drugs Product Scope
1.1.2 Neuropathic Pain Drugs Market Status and Outlook
1.2 Global Neuropathic Pain Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neuropathic Pain Drugs Market Size by Region (2018-2029)
1.4 Global Neuropathic Pain Drugs Historic Market Size by Region (2018-2023)
1.5 Global Neuropathic Pain Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neuropathic Pain Drugs Market Size (2018-2029)
1.6.1 North America Neuropathic Pain Drugs Market Size (2018-2029)
1.6.2 Europe Neuropathic Pain Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Neuropathic Pain Drugs Market Size (2018-2029)
1.6.4 Latin America Neuropathic Pain Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Neuropathic Pain Drugs Market Size (2018-2029)
2 Neuropathic Pain Drugs Market by Type
2.1 Introduction
2.1.1 Tricyclic Anti-Depressants Anticonvulsants
2.1.2 Serotonin-Norepinephrine Reuptake Inhibitor
2.1.3 Capsaicin Cream
2.1.4 Local Anaesthesia
2.1.5 Opioids
2.1.6 Steroids
2.1.7 Others
2.2 Global Neuropathic Pain Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neuropathic Pain Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Neuropathic Pain Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neuropathic Pain Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neuropathic Pain Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neuropathic Pain Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neuropathic Pain Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neuropathic Pain Drugs Revenue Breakdown by Type (2018-2029)
3 Neuropathic Pain Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Neuropathic Pain Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neuropathic Pain Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Neuropathic Pain Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neuropathic Pain Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neuropathic Pain Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neuropathic Pain Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neuropathic Pain Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neuropathic Pain Drugs Revenue Breakdown by Application (2018-2029)
4 Neuropathic Pain Drugs Competition Analysis by Players
4.1 Global Neuropathic Pain Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuropathic Pain Drugs as of 2022)
4.3 Date of Key Players Enter into Neuropathic Pain Drugs Market
4.4 Global Top Players Neuropathic Pain Drugs Headquarters and Area Served
4.5 Key Players Neuropathic Pain Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Neuropathic Pain Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Neuropathic Pain Drugs Products, Services and Solutions
5.1.4 Pfizer Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Neuropathic Pain Drugs Products, Services and Solutions
5.2.4 Johnson & Johnson Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson & Johnson Recent Developments
5.3 Sanofi
5.3.1 Sanofi Profile
5.3.2 Sanofi Main Business
5.3.3 Sanofi Neuropathic Pain Drugs Products, Services and Solutions
5.3.4 Sanofi Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 GlaxoSmithKline Recent Developments
5.4 GlaxoSmithKline
5.4.1 GlaxoSmithKline Profile
5.4.2 GlaxoSmithKline Main Business
5.4.3 GlaxoSmithKline Neuropathic Pain Drugs Products, Services and Solutions
5.4.4 GlaxoSmithKline Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 GlaxoSmithKline Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Profile
5.5.2 Eli Lilly Main Business
5.5.3 Eli Lilly Neuropathic Pain Drugs Products, Services and Solutions
5.5.4 Eli Lilly Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lilly Recent Developments
5.6 Bristol-Myers Squibb
5.6.1 Bristol-Myers Squibb Profile
5.6.2 Bristol-Myers Squibb Main Business
5.6.3 Bristol-Myers Squibb Neuropathic Pain Drugs Products, Services and Solutions
5.6.4 Bristol-Myers Squibb Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Bristol-Myers Squibb Recent Developments
5.7 Biogen
5.7.1 Biogen Profile
5.7.2 Biogen Main Business
5.7.3 Biogen Neuropathic Pain Drugs Products, Services and Solutions
5.7.4 Biogen Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Biogen Recent Developments
5.8 Baxter Healthcare
5.8.1 Baxter Healthcare Profile
5.8.2 Baxter Healthcare Main Business
5.8.3 Baxter Healthcare Neuropathic Pain Drugs Products, Services and Solutions
5.8.4 Baxter Healthcare Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Baxter Healthcare Recent Developments
5.9 Depomed
5.9.1 Depomed Profile
5.9.2 Depomed Main Business
5.9.3 Depomed Neuropathic Pain Drugs Products, Services and Solutions
5.9.4 Depomed Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Depomed Recent Developments
6 North America
6.1 North America Neuropathic Pain Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Neuropathic Pain Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neuropathic Pain Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neuropathic Pain Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neuropathic Pain Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neuropathic Pain Drugs Market Dynamics
11.1 Neuropathic Pain Drugs Industry Trends
11.2 Neuropathic Pain Drugs Market Drivers
11.3 Neuropathic Pain Drugs Market Challenges
11.4 Neuropathic Pain Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
